Adnexus Therapeutics
Latest round
- Series C
Last raised
- Aug 2007
Total raised
- $48M
Investors
- 5
About Adnexus Therapeutics
Adnexus is a US based pharmaceutical company, engaged in the discovery and development of Adnectins™, a proprietary type of targeted biologic. Adnectins are proteins designed to either block or stimulate therapeutic targets of interest to help fight diseases across a broad range of therapeutic areas.
Who invested in Adnexus Therapeutics
5 investors across 3 rounds
See all investors in Adnexus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Adnexus Therapeutics
Who invested in Adnexus Therapeutics?
Adnexus Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Adnexus Therapeutics raised?
Adnexus Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Adnexus Therapeutics last raise money?
Adnexus Therapeutics's most recent round on record is a Series C, in Aug 2007.
What does Adnexus Therapeutics do?
Adnexus is a US based pharmaceutical company, engaged in the discovery and development of Adnectins™, a proprietary type of targeted biologic.
Where is Adnexus Therapeutics headquartered?
Adnexus Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Adnexus Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Adnexus Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Adnexus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.